Clinical Trial Update: A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study to assess safety and effects of single and multiple doses of KS101 in healthy volunteers; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Chronic Kidney Disease

Drugs mentioned

• KS101

Snippet

Sponsor: Klotho Sciences Australia Pty Ltd. | Conditions: Healthy Participants, Alzheimer Disease | Phase 1 | Status: NOT_YET_RECRUITING